Worksport Ltd

Securities Trading Plans

During the six months ended June 30, 2025, none of our Section 16 officers or directors (as defined in Rule 16a-1(f) of the Exchange Act)adopted orterminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Section 408(c) of Regulation S-K).

Subsequent Events

On July 12, 2025, the Company granted employees an aggregate of 91,940 stock options priced at the closing stock price on July 11, 2025, vesting 50% at the end of the following two annual anniversaries from grant date, and expiring 10 years from grant date. Under these same terms, the Company granted directors an aggregate of 10,000 stock options. On July 12, 2025, the Company granted Steven Rossi 215,000 stock options priced at the closing stock price on July 11, 2025, vesting 50% at the end of the following two annual anniversaries from grant date, and expiring 10 years from grant date. On July 12, 2025, the Company granted a director 50,000 stock options priced at the closing stock price on July 11, 2025, vesting pursuant to a performance milestone, and expiring 10 years from grant date. On July 12, 2025, the Company granted a consultant 76,500 stock options priced at the closing stock price on July 11, 2025, vesting pursuant to performance milestones, and expiring 10 years from grant date. On July 14, 2025 the Company signed a lease agreement for 1,992 square feet of office space to be used as an R&D facility for its Terravis Energy subsidiary pursuant to a two year lease effective July 18,2025 for an average monthly rent of $3,154.

On August 1, 2025, the Company submitted a $3 million purchase order and placed a deposit with an established manufacturing equipment supplier for additional machinery, with delivery currently expected in the second quarter of 2026. This additional equipment is expected to meaningfully increase production capacity at the Company’s West Seneca, NY manufacturing facility, enabling the Company to meet anticipated customer demand more efficiently, improve operational throughput, and support future revenue growth.